Marta Hidalgo-Pujol1, Sebastiano Biondo2, Javier Die Trill3, Vincenzo Vigorita4, Marta Paniagua Garcia-Señorans4, Isabel Pascual Migueláñez5, Fernando Prieto-La Noire5, Ander Timoteo6, Lidia Cornejo7, José Ignacio Martín Parra8, María Fidalgo García9, Alejandro Solís-Peña10, Arturo Cirera de Tudela11, Araceli Rodriguez González12, Luís Sánchez-Guillen13, Carlos Bustamante Recuenco14, Carla Pérez-Alonso15, Elena Hurtado Caballero16, Marta Pascual17, Javier García Septiem18, Laura Mora López19, Jorge Cervera-Aldama20, Héctor Guadalajara21, Eloy Espín10, Esther Kreisler2. 1. Department of General and Digestive Surgery, Coloproctology Unit, Bellvitge University Hospital, Barcelona, Spain; University of Barcelona and IBIDELL (Bellvitge Biomedical Investigation Institute), Barcelona, Spain. Electronic address: mhidalgopujol@gmail.com. 2. Department of General and Digestive Surgery, Coloproctology Unit, Bellvitge University Hospital, Barcelona, Spain; University of Barcelona and IBIDELL (Bellvitge Biomedical Investigation Institute), Barcelona, Spain. 3. Department of General and Digestive Surgery, Coloproctology Unit, Ramón y Cajal University Hospital, Madrid, Spain. 4. Division of Coloproctology, Department of General and Digestive Surgery, University Hospital Complex of Vigo, Vigo, Spain; General Surgery Research Group, SERGAS-UVIGO, Galicia Sur Health Research Institute (IIS Galicia Sur), Vigo, Spain. 5. Department of General and Digestive Surgery, La Paz University Hospital, Madrid, Spain. 6. Department of General and Digestive Surgery, Doctor Josep Trueta University Hospital, Girona, Spain. 7. General and digestive surgery research group. Girona Biomedical Research Institute (IDIBGI), Girona, Spain. 8. Division of Coloproctology, Department of General and Digestive Surgery, Marqués de Valdecilla University Hospital, Santander, Spain. 9. Department of General and Digestive Surgery, Marqués de Valdecilla University Hospital, Santander, Spain. 10. Department of General and Digestive Surgery, Coloproctology Unit, Vall d'Hebron University Hospital, Autonomic University of Barcelona, Barcelona, Spain. 11. Department of General and Digestive Surgery, Vall d'Hebron University Hospital, Barcelona, Spain. 12. Department of General and Digestive Surgery, Emergency Surgery Unit, Donostia University Hospital, San Sebastián, Spain. 13. Department of General and Digestive Surgery, Coloproctology Unit, Elche University Hospital, Alicante, Spain. 14. Department of General and Digestive Surgery, Nuestra Señora del Prado Hospital, Talavera de la Reina, Toledo, Spain. 15. Department of General and Digestive Surgery, La Fe University Hospital, Valencia, Spain. 16. Department of General and Digestive Surgery, Coloproctology Unit, Gregorio Marañón University Hospital, Madrid, Spain. 17. Department of General and Digestive Surgery, Coloproctology Unit, Hospital del Mar, Barcelona, Spain. 18. Department of General and Digestive Surgery, La Princesa University Hospital, Madrid, Spain. 19. Department of General and Digestive Surgery, Parc Taulí University Hospital, Sabadell, Spain. 20. Coloproctology Unit. General and Digestive Surgery Department. Cruces University Hospital. Barakaldo, Bizkaia, Spain. 21. Department of General and Digestive Surgery, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Abstract
BACKGROUND: Oncological outcomes of self-expanding metallic stent used as a bridge to surgery in potential curative patients with left-sided colonic cancer obstruction remain unclear. The aim of this study was to investigate perioperative and mid-term oncological outcomes of 2 of the currently most commonly performed treatments in left-sided colonic cancer obstruction. METHODS: This is a retrospective multicenter study including patients with left-sided colonic cancer obstruction treated with curative intent between 2013 and 2017. The presence of metastasis at diagnosis was an exclusion criterion. The primary outcome was to evaluate the noninferiority, in terms of overall survival, of bridge to surgery strategy compared with emergency colonic resection. The secondary outcomes were perioperative morbimortality, disease free survival, local recurrence, and distant recurrence. RESULTS: A total of 564 patients were included, 320 in the emergency colonic resection group and 244 in the bridge to surgery group. Twenty-seven patients of the bridge-to-surgery group needed urgent operation. Postoperative morbidity rates were statistically higher in the emergency colonic resection group (odds ratio [95% confidence interval] 0.37 [0.24-0.55], P < .001). There was no difference in 90-day mortality between groups (odds ratio [95% confidence interval] 0.85 [0.36-1.99], P = .702). The median follow-up was 3.80 years (2.29-4.92). The results show the noninferiority of bridge to surgery versus emergency colonic resection in terms of overall survival (hazard ratio [95% confidence interval) 0.78 [0.56-1.07], P = .127). There were no differences in disease free survival, distant recurrence, and local recurrence rates between bridge to surgery and emergency colonic resection groups. CONCLUSION: Self-expanding metallic stent as bridge to surgery might not lead to a negative impact on the long-term prognosis of the tumor compared with emergency colonic resection in expert hands and selected patients.
BACKGROUND: Oncological outcomes of self-expanding metallic stent used as a bridge to surgery in potential curative patients with left-sided colonic cancer obstruction remain unclear. The aim of this study was to investigate perioperative and mid-term oncological outcomes of 2 of the currently most commonly performed treatments in left-sided colonic cancer obstruction. METHODS: This is a retrospective multicenter study including patients with left-sided colonic cancer obstruction treated with curative intent between 2013 and 2017. The presence of metastasis at diagnosis was an exclusion criterion. The primary outcome was to evaluate the noninferiority, in terms of overall survival, of bridge to surgery strategy compared with emergency colonic resection. The secondary outcomes were perioperative morbimortality, disease free survival, local recurrence, and distant recurrence. RESULTS: A total of 564 patients were included, 320 in the emergency colonic resection group and 244 in the bridge to surgery group. Twenty-seven patients of the bridge-to-surgery group needed urgent operation. Postoperative morbidity rates were statistically higher in the emergency colonic resection group (odds ratio [95% confidence interval] 0.37 [0.24-0.55], P < .001). There was no difference in 90-day mortality between groups (odds ratio [95% confidence interval] 0.85 [0.36-1.99], P = .702). The median follow-up was 3.80 years (2.29-4.92). The results show the noninferiority of bridge to surgery versus emergency colonic resection in terms of overall survival (hazard ratio [95% confidence interval) 0.78 [0.56-1.07], P = .127). There were no differences in disease free survival, distant recurrence, and local recurrence rates between bridge to surgery and emergency colonic resection groups. CONCLUSION: Self-expanding metallic stent as bridge to surgery might not lead to a negative impact on the long-term prognosis of the tumor compared with emergency colonic resection in expert hands and selected patients.
Authors: Antonietta Lamazza; Maria Vittoria Carati; Anna Maria Pronio; Enrico Fiori; Angelo Antoniozzi; Antonio V Sterpetti Journal: Surgery Date: 2022-07-14 Impact factor: 4.348